IDH1 mutations were associated with increased overall survival of GBM patients and occurred preferentially in young patients and those with secondary GBM [23], that is GBM progressing from a lower grade glioma as opposed to GBMs that arise de novo, i.e., primary GBM. The gene discussed is IDH1; the disease is glioma.